Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 89
Filter
1.
J Am Heart Assoc ; 10(16): e020528, 2021 08 17.
Article in English | MEDLINE | ID: mdl-34387132

ABSTRACT

Background Evidence suggests intracerebral hemorrhage survivors have earlier recovery compared with ischemic stroke survivors. The Centers for Medicare and Medicaid Services prospective payment system instituted documentation rules for inpatient rehabilitation facilities (IRFs) in 2010, with the goal of optimizing patient selection. We investigated whether these requirements limited IRF and increased skilled nursing facility (SNF) use compared with home discharge. Methods and Results Intracerebral hemorrhage discharges to IRF, SNF, or home were estimated using GWTG (Get With The Guidelines) Stroke registry data between January 1, 2008, and December 31, 2015 (n=265 444). Binary hierarchical models determined associations between the 2010 Rule and discharge setting; subgroup analyses evaluated age, geographic region, and hospital type. From January 1, 2008, to December 31, 2009, 45.5% of patients with intracerebral hemorrhage had home discharge, 22.2% went to SNF, and 32.3% went to IRF. After January 1, 2010, there was a 1.06% absolute increase in home discharge, a 0.46% increase in SNF, and a 1.52% decline in IRF. The adjusted odds of IRF versus home discharge decreased 3% after 2010 (adjusted odds ratio [aOR], 0.97; 95% CI, 0.95-1.00). Lower odds of IRF versus home discharge were observed in people aged <65 years (aOR, 0.92; 95% CI, 0.89-0.96), Western states (aOR, 0.89; 95% CI, 0.84-0.95), and nonteaching hospitals (aOR, 0.90; 95% CI, 0.86-0.95). Adjusted odds of SNF versus home discharge increased 14% after 2010 (aOR, 1.14; 95% CI, 1.11-1.18); there were significant associations in all age groups, the Northeast, the South, the Midwest, and teaching hospitals. Conclusions The Centers for Medicare and Medicaid Services 2010 IRF prospective payment system Rule resulted in fewer discharges to IRF and more discharges to SNF in patients with intracerebral hemorrhage. Health policy changes potentially affect access to intensive postacute rehabilitation.


Subject(s)
Cerebral Hemorrhage/rehabilitation , Health Care Reform , Medicare , Outcome and Process Assessment, Health Care/trends , Patient Discharge/trends , Prospective Payment System , Rehabilitation Centers/trends , Skilled Nursing Facilities/trends , Adult , Aged , Aged, 80 and over , Female , Health Care Reform/economics , Health Care Reform/legislation & jurisprudence , Health Services Accessibility/trends , Humans , Inpatients , Male , Medicare/economics , Medicare/legislation & jurisprudence , Middle Aged , Outcome and Process Assessment, Health Care/economics , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Patient Discharge/economics , Patient Discharge/legislation & jurisprudence , Policy Making , Prospective Payment System/economics , Prospective Payment System/legislation & jurisprudence , Registries , Rehabilitation Centers/economics , Rehabilitation Centers/legislation & jurisprudence , Skilled Nursing Facilities/economics , Skilled Nursing Facilities/legislation & jurisprudence , Time Factors , Treatment Outcome , United States
2.
Methodist Debakey Cardiovasc J ; 16(3): 192-198, 2020.
Article in English | MEDLINE | ID: mdl-33133354

ABSTRACT

The American health care system has many great successes, but there continue to be opportunities for improving quality, access, and cost. The fee-for-service health care paradigm is shifting toward value-based care and will require accountability around quality assurance and cost reduction. As a result, many health care entities are rallying health care providers, administrators, regulators, and patients around a national imperative to create a culture of safety and develop systems of care to improve health care quality. However, the culture of patient safety and quality requires rigorous assessment of outcomes, and while numerous data collection and decision support tools are available to assist in quality assessment and performance improvement, the public reporting of this data can be confusing to patients and physicians alike and result in unintended negative consequences. This review explores the aims of health care reform, the national efforts to create a culture of quality and safety, the principles of quality improvement, and how these principles can be applied to patient care and medical practice.


Subject(s)
Cardiac Surgical Procedures/standards , Health Care Reform/standards , Outcome and Process Assessment, Health Care/standards , Patient Safety/standards , Quality Improvement/standards , Quality Indicators, Health Care/standards , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/legislation & jurisprudence , Cardiac Surgical Procedures/mortality , Fee-for-Service Plans/standards , Health Care Reform/legislation & jurisprudence , Health Policy , Humans , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Patient Safety/legislation & jurisprudence , Policy Making , Quality Improvement/legislation & jurisprudence , Quality Indicators, Health Care/legislation & jurisprudence , Risk Assessment , Risk Factors , Treatment Outcome
6.
Semin Thorac Cardiovasc Surg ; 31(1): 32-37, 2019.
Article in English | MEDLINE | ID: mdl-30102970

ABSTRACT

Medicare's Bundle Payment for Care Improvement (BPCI) Model 2 groups reimbursement for valve surgery into 90-day episodes of care, which include operative costs, inpatient stay, physician fees, postacute care, and readmissions up to 90 days postprocedure. We analyzed our BPCI patients' 90-day outcomes to understand the late financial risks and implications of the bundle payment system for valve patients. All BPCI valve patients from October 2013 (start of risk-sharing phase) to December 2015 were included. Readmissions were categorized as early (≤30 days) or late (31-90 days). Data were collected from institutional databases as well as Medicare claims. Analysis included 376 BPCI valve patients: 202 open and 174 transcatheter aortic valves (TAVR). TAVR patients were older (83.6 vs 73.8 years; P = 0.001) and had higher Society of Thoracic Surgery predicted risk (7.1% vs 2.8%; P = 0.001). Overall, 18.6% of patients (70/376) had one-or-more 90-day readmission, and total claim was on average 51% greater for these patients. Overall readmissions were more common among TAVR patients (22.4% (39/174) vs 15.3% (31/202), P = 0.052) as was late readmission. TAVR patients had significantly higher late readmission claims, and early readmission was predictive of late readmission for TAVR patients only (P = 0.04). Bundled claims for a 90-day episode of care are significantly increased in patients with readmissions. TAVR patients represent a high-risk group for late readmission, possibly a reflection of their chronic disease processes. Being able to identify patients at highest risk for 90-day readmission and the associated claims will be valuable as we enter into risk-bearing episodes of care agreements with Medicare.


Subject(s)
Cardiac Surgical Procedures/economics , Health Policy/economics , Heart Valve Diseases/economics , Heart Valve Diseases/surgery , Hospital Costs , Outcome and Process Assessment, Health Care/economics , Patient Care Bundles/economics , Patient Readmission/economics , Aged , Aged, 80 and over , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/legislation & jurisprudence , Cardiac Surgical Procedures/mortality , Centers for Medicare and Medicaid Services, U.S./economics , Cost Savings , Cost-Benefit Analysis , Databases, Factual , Female , Health Policy/legislation & jurisprudence , Heart Valve Diseases/diagnosis , Heart Valve Diseases/mortality , Hospital Costs/legislation & jurisprudence , Humans , Male , Medicare/economics , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Patient Readmission/legislation & jurisprudence , Policy Making , Reimbursement Mechanisms/economics , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome , United States
7.
Circ Cardiovasc Qual Outcomes ; 11(7): e004729, 2018 07.
Article in English | MEDLINE | ID: mdl-29946015

ABSTRACT

BACKGROUND: Heart failure (HF) is the leading cause of morbidity and mortality in the United States. Despite advancement in the management of HF, outcomes remain suboptimal, particularly among the uninsured. In 2014, the Affordable Care Act expanded Medicaid eligibility, and millions of low-income adults gained insurance. Little is known about Medicaid expansion's effect on inpatient HF care. METHODS AND RESULTS: We used the American Heart Association's Get With The Guidelines-Heart Failure registry to assess changes in inpatient care quality and outcomes among low-income patients (<65 years old) hospitalized for HF after Medicaid expansion, in expansion, and nonexpansion states. Patients were classified as low-income if covered by Medicaid, uninsured, or missing insurance. Expansion states were those that implemented expansion in 2014. Piecewise logistic multivariable regression models were constructed to track quarterly trends of quality and outcome measures in the pre (January 1, 2010-December 31, 2013) and postexpansion (January 1, 2014-June 30, 2017) periods. These measures were compared between expansion versus nonexpansion states during the postexpansion period. The cohort included 58 804 patients hospitalized across 391 sites. In states that expanded Medicaid, uninsured HF hospitalizations declined from 7.9% to 4.4%, and Medicaid HF hospitalizations increased from 18.3% to 34.6%. Defect-free HF care was increasing during the preexpansion period (adjusted odds ratio/quarter, 1.06; 95% confidence interval, 1.03-1.08) but did not change after expansion (adjusted odds ratio, 0.99; 95% confidence interval, 0.97-1.02). Patterns were similar for other quality measures. There were no quality measures for which the rate of improvement sped up after expansion. In-hospital mortality rates remained similar during the preexpansion (adjusted odds ratio, 0.99; 95% confidence interval, 0.96-1.02) and postexpansion periods (adjusted odds ratio, 1.00; 95% confidence interval, 0.97-1.03). Among nonexpansion states, uninsured HF hospitalizations increased (11.6% to 16.7%) as did Medicaid HF hospitalizations (17.9% to 26.6%), and no quarterly improvement was observed for most quality measures in the post compared with preexpansion period. During the postexpansion period, defect-free care and mortality did not differ between expansion and nonexpansion states. CONCLUSIONS: Medicaid expansion was associated with a significant decline in uninsured HF hospitalizations but not improvements in quality of care or in-hospital mortality among sites participating in a national quality improvement initiative. Efforts beyond insurance expansion are needed to improve in-hospital outcomes for low-income patients with HF.


Subject(s)
Eligibility Determination , Heart Failure/therapy , Hospitalization , Medicaid , Outcome and Process Assessment, Health Care , Patient Protection and Affordable Care Act , Poverty , Quality Indicators, Health Care , Aged , Eligibility Determination/economics , Eligibility Determination/legislation & jurisprudence , Female , Healthcare Disparities , Heart Failure/diagnosis , Heart Failure/economics , Heart Failure/mortality , Hospital Mortality , Hospitalization/economics , Hospitalization/legislation & jurisprudence , Humans , Male , Medicaid/economics , Medicaid/legislation & jurisprudence , Middle Aged , Outcome and Process Assessment, Health Care/economics , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Patient Protection and Affordable Care Act/economics , Patient Protection and Affordable Care Act/legislation & jurisprudence , Policy Making , Poverty/economics , Poverty/legislation & jurisprudence , Quality Improvement , Quality Indicators, Health Care/economics , Quality Indicators, Health Care/legislation & jurisprudence , Registries , Time Factors , Treatment Outcome , United States/epidemiology
10.
Int J Law Psychiatry ; 47: 18-27, 2016.
Article in English | MEDLINE | ID: mdl-27055603

ABSTRACT

Laws governing the detention and treatment of mentally disordered offenders (MDOs) vary widely across Europe, yet little information is available about the features of these laws and their comparative advantages and disadvantages. The purpose of this article is to compare the legal framework governing detention in forensic psychiatric care in three European countries with long-established services for MDOs, England, Germany and the Netherlands. A literature review was conducted alongside consultation with experts from each country. We found that the three countries differ in several areas, including criteria for admission, review of detention, discharge process, the concept of criminal responsibility, service provision and treatment philosophy. Our findings suggest a profound difference in how each country relates to MDOs, with each approach contributing to different pathways and potentially different outcomes for the individual. Hopefully making these comparisons will stimulate debate and knowledge exchange on an international level to aid future research and the development of best practice in managing this population.


Subject(s)
Commitment of Mentally Ill/legislation & jurisprudence , Cross-Cultural Comparison , Prisoners/legislation & jurisprudence , Prisoners/psychology , Commitment of Mentally Ill/trends , England , Germany , Homicide/legislation & jurisprudence , Homicide/psychology , Homicide/trends , Humans , Length of Stay/legislation & jurisprudence , Mental Competency/legislation & jurisprudence , Mental Competency/psychology , Netherlands , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Patient Discharge/legislation & jurisprudence , Patient Discharge/trends , Security Measures/legislation & jurisprudence , Wales
11.
Enferm. glob ; 15(42): 341-352, abr. 2016.
Article in Spanish | IBECS | ID: ibc-150812

ABSTRACT

Este estudio tuvo como objetivo analizar de acuerdo a la perspectiva de las enfermeras, los factores o dificultades que limitan la aplicación de sistematización de la asistencia de enfermería relacionados con la gestión de recursos humanos en los hospitales donde trabajan. Se trata de un estudio cualitativo, basado en el marco de la hermenéutica-dialéctica. La muestra estuvo conformada por 32 enfermeras de tres hospitales en una ciudad en el sur de Minas Gerais. Se utilizó el grupo focal con la pregunta guía: '¿La gestión de los recursos humanos en enfermería conlleva dificultades en la implementación de la sistematización de la atención de enfermería?'. Después de las entrevistas, los discursos fueron transcritos totalmente. El análisis de contenido permitió extraer la gestión de categorías de los recursos humanos y las dificultades para la sistematización de la asistencia de enfermería en el trabajo diario de enfermería. Los resultados mostraron que puntos de dificultad tales como: reducción del número de empleados, el absentismo, la rotación y la falta de compromiso con la profesión, donde establecer un dimensionado correspondiente del marco de enfermería es esencial para asegurar la excelencia de la asistencia al cliente. Sin embargo, para la puesta en marcha con éxito de la sistematización de la asistencia de enfermería es necesario tener en cuenta el número de personal de enfermería, la asistencia de la complejidad requerida por los pacientes e incluso superar la resistencia de algunas enfermeras que todavía no entienden la sistematización de la asistencia de enfermería como un respaldo legal de la profesión (AU)


Este estudo teve como objetivo analisar de acordo com a perspectiva de enfermeiros, fatores limitantes ou dificultadores para a implementação da sistematização da assistência de enfermagem relacionados ao gerenciamento de recursos humanos nas instituições hospitalares em que atuam. Trata-se de um estudo qualitativo, fundamentado no referencial da Hermenêutica-Dialética. A amostra constituiu-se de 32 enfermeiros de três Hospitais de um município do Sul de Minas Gerais. Utilizou-se o Grupo Focal com a questão norteadora: 'O gerenciamento de recursos humanos na enfermagem acarreta dificuldades na implementação da sistematização da assistência de enfermagem?'. Após as entrevistas, as falas foram transcritas na íntegra. A análise de conteúdo possibilitou extrair a categoria Gerenciamento de recursos humanos e as dificuldades para a sistematização da assistência de enfermagem no cotidiano de trabalho do enfermeiro. Os resultados mostraram pontos dificultadores, tais como: número reduzido de funcionários, absenteísmo, rotatividade e falta de compromisso com a profissão, onde estabelecer um correspondente dimensionamento do quadro de enfermagem é imprescindível para se garantir uma assistência de excelência à clientela. No entanto, para o sucesso da operacionalização da sistematização da assistência de enfermagem é necessário considerar o número do pessoal de enfermagem, a complexidade de assistência requerida pelos pacientes e ainda vencer a resistência por parte de alguns enfermeiros que ainda não compreendem a sistematização da assistência de enfermagem como respaldo legal da profissão (AU)


This study aimed to analyze according to the perspective of nurses, limiting factors or difficulties to the implementation of systematization of nursing care related to human resources management in the hospital institutions where they work. This is a qualitative study, based on the reference of Hermeneutics-Dialectics. The sample consisted of 32 nurses from three Hospitals in a city in southern Minas Gerais. The Focus Group was used, with the following guiding question: 'Does the management of human resources in nursing brings on difficulties in implementing the systematization of nursing care?' After the interviews, the speeches were fully transcribed. The content analysis enabled to extract the category Management of human resources and the difficulties for the systematization of nursing care in nursing daily work. The results showed hindering points, such as: reduced number of employees, absenteeism, turnover and lack of commitment to the profession, where establishing a corresponding dimensioning of the nursing framework is essential to ensure the excellence of customer assistance. However, for the successful operationalization of the systematization of nursing care is necessary to consider the number of nursing staff, the complexity of assistance required by patients, and also overcome resistance by some nurses who do not yet understand the systematization of nursing care as a legal profession support (AU)


Subject(s)
Humans , Male , Female , Nursing Care , Nursing Care/organization & administration , Nursing Care/standards , Workforce , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Outcome and Process Assessment, Health Care/organization & administration , Outcome and Process Assessment, Health Care/standards , Outcome Assessment, Health Care/organization & administration , Outcome Assessment, Health Care/standards , Outcome Assessment, Health Care
13.
Minn Med ; 97(8): 49-51, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25226655

ABSTRACT

The Agency for Healthcare Research and Quality (AHRQ) has funded systematic reviews of comparative effectiveness research in 17 areas over the last 10 years as part of a federal mandate. These reviews provide a reliable and unbiased source of comprehensive information about the effectiveness and risks of treatment alternatives for patients and clinicians. This article describes comparative effectiveness research, provides an overview of how physicians can use it in clinical practice, and references important contributions made by the Minnesota Evidence-based Practice Center.


Subject(s)
Comparative Effectiveness Research/legislation & jurisprudence , Comparative Effectiveness Research/organization & administration , Evidence-Based Medicine/legislation & jurisprudence , Evidence-Based Medicine/organization & administration , Health Priorities/legislation & jurisprudence , Health Priorities/organization & administration , Health Services Research/legislation & jurisprudence , Health Services Research/organization & administration , Humans , Minnesota , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Outcome and Process Assessment, Health Care/organization & administration , Patient Education as Topic/legislation & jurisprudence , Patient Education as Topic/organization & administration , Practice Guidelines as Topic
14.
Nephrology (Carlton) ; 19(10): 599-604, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24995599

ABSTRACT

According to the Indian chronic kidney disease registry, in 2010 only 2% of end stage kidney disease patients were managed with kidney transplantation, 37% were managed with dialysis and 61% were treated conservatively without renal replacement therapy. In countries like India, where a well-organized deceased donor kidney transplantation program is not available, living donor kidney transplantation is the major source of organs for kidney transplantation. The most common reason to decline a donor for directed living donation is ABO incompatibility, which eliminates up to one third of the potential living donor pool. Because access to transplantation with human leukocyte antigen (HLA)-desensitization protocols and ABO incompatible transplantation is very limited due to high costs and increased risk of infections from more intense immunosuppression, kidney paired donation (KPD) promises hope to a growing number of end stage kidney disease patients. KPD is a rapidly growing and cost-effective living donor kidney transplantation strategy for patients who are incompatible with their healthy, willing living donor. In principle, KPD is feasible for any centre that performs living donor kidney transplantation. In transplant centres with a large living donor kidney transplantation program KPD does not require extra infrastructure, decreases waiting time, avoids transplant tourism and prevents commercial trafficking. Although KPD is still underutilized in India, it has been performed more frequently in recent times. To substantially increase donor pool and transplant rates, transplant centres should work together towards a national KPD program and frame a uniform acceptable allocation policy.


Subject(s)
Developing Countries , Directed Tissue Donation , Health Resources/organization & administration , Health Services Accessibility/organization & administration , Healthcare Disparities , Kidney Failure, Chronic/surgery , Kidney Transplantation , Living Donors/supply & distribution , Outcome and Process Assessment, Health Care/organization & administration , Cost-Benefit Analysis , Developing Countries/economics , Directed Tissue Donation/economics , Directed Tissue Donation/legislation & jurisprudence , Health Care Costs , Health Policy , Health Resources/economics , Health Resources/legislation & jurisprudence , Health Services Accessibility/economics , Health Services Accessibility/legislation & jurisprudence , Healthcare Disparities/economics , Healthcare Disparities/legislation & jurisprudence , Histocompatibility , Humans , India/epidemiology , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/economics , Kidney Failure, Chronic/epidemiology , Kidney Transplantation/adverse effects , Kidney Transplantation/economics , Kidney Transplantation/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Outcome and Process Assessment, Health Care/economics , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Policy Making , Time Factors , Treatment Outcome , Waiting Lists
15.
BMC Public Health ; 14: 496, 2014 May 23.
Article in English | MEDLINE | ID: mdl-24886092

ABSTRACT

BACKGROUND: There are few Australian studies showing how research evidence is used to inform the development of public health policy. International research has shown that compensation for injury rehabilitation can have negative impacts on health outcomes. This study examined transport injury compensation policy in the Australian state of Victoria to: determine type and purpose of reference to information sources; and to identify the extent of reference to academic research evidence in transport related injury rehabilitation compensation policy. METHODS: Quantitative content analysis of injury rehabilitation compensation policies (N = 128) from the Victorian state government transport accident compensation authority. RESULTS: The most commonly referenced types of information were Internal Policy (median = 6 references per policy), Clinical/Medical (2.5), and Internal Legislation (1). Academic Research Evidence was the least often referenced source of information. The main purpose of reference to information was to support injury treatment and rehabilitation compensation claims decision-making. CONCLUSIONS: Transport injury compensation policy development is complex; with multiple sources of information cited including legislation, internal policy, external policy and clinical/medical evidence. There is limited use of academic research evidence in Victorian state government injury treatment and rehabilitation compensation policies. Decisions regarding compensation for injury treatment and rehabilitation services could benefit from greater use of academic research evidence. This study is one of the first to examine the use of research evidence in existing Australian public health policy decision-making using rigorous quantitative methods. It provides a practical example of how use of research evidence in public health policy can be objectively measured.


Subject(s)
Evidence-Based Practice/statistics & numerical data , Outcome and Process Assessment, Health Care/statistics & numerical data , Policy Making , Public Policy/legislation & jurisprudence , Research/statistics & numerical data , State Government , Australia , Compensation and Redress/legislation & jurisprudence , Decision Making , Epidemiologic Research Design , Humans , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Victoria , Wounds and Injuries/rehabilitation
17.
Z Evid Fortbild Qual Gesundhwes ; 107(8): 548-59, 2013.
Article in German | MEDLINE | ID: mdl-24290669

ABSTRACT

The aim of the WINHO indicators project is to describe and enhance the quality of outpatient oncology care in Germany with indicators. This paper deals with the development of a set of evidence- and consensus-based meaningful indicators to assess the quality of outpatient oncology care in Germany. These indicators are intended to be applied in assessments of quality of patient care in oncology practices, in quality reports and in peer-to-peer benchmarking. A set of 272 already existing indicators was identified through internet and literature searches. After redundancy reduction and addition of newly developed indicators for areas of ambulatory oncology care that were not yet covered, a preliminary set of 67 indicators was established. The further development of the indicator set was based on a modified version of the two-step RAND/UCLA expert evaluation method, which has been internationally established for developing quality indicator sets. The indicators were modified after the first round of ratings. After completing and assessing the second round of ratings, a set of 46 homogeneously positively rated quality indicators is now available for outpatient oncology care in Germany.


Subject(s)
Ambulatory Care/legislation & jurisprudence , Ambulatory Care/organization & administration , Medical Oncology/legislation & jurisprudence , Medical Oncology/organization & administration , National Health Programs/legislation & jurisprudence , National Health Programs/organization & administration , Quality Assurance, Health Care/legislation & jurisprudence , Quality Assurance, Health Care/organization & administration , Quality Indicators, Health Care/legislation & jurisprudence , Quality Indicators, Health Care/organization & administration , Benchmarking/legislation & jurisprudence , Benchmarking/organization & administration , Breast Neoplasms/therapy , Colorectal Neoplasms/therapy , Consensus , Evidence-Based Medicine/legislation & jurisprudence , Evidence-Based Medicine/organization & administration , Germany , Health Services Research/legislation & jurisprudence , Health Services Research/organization & administration , Humans , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Outcome and Process Assessment, Health Care/organization & administration
18.
Expert Rev Pharmacoecon Outcomes Res ; 13(4): 417-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23977967

Subject(s)
Biomedical Technology , Child Health Services , Comparative Effectiveness Research , Delivery of Health Care , Evidence-Based Medicine , Outcome and Process Assessment, Health Care , Technology Assessment, Biomedical , Biomedical Technology/economics , Biomedical Technology/legislation & jurisprudence , Biomedical Technology/organization & administration , Child , Child Health Services/economics , Child Health Services/legislation & jurisprudence , Child Health Services/organization & administration , Comparative Effectiveness Research/economics , Comparative Effectiveness Research/legislation & jurisprudence , Comparative Effectiveness Research/organization & administration , Cost-Benefit Analysis , Delivery of Health Care/economics , Delivery of Health Care/legislation & jurisprudence , Delivery of Health Care/organization & administration , Evidence-Based Medicine/economics , Evidence-Based Medicine/legislation & jurisprudence , Evidence-Based Medicine/organization & administration , Health Care Costs , Health Policy , Humans , Models, Organizational , Outcome and Process Assessment, Health Care/economics , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Outcome and Process Assessment, Health Care/organization & administration , Policy Making , Quality Improvement , Quality Indicators, Health Care , Quality-Adjusted Life Years , Technology Assessment, Biomedical/economics , Technology Assessment, Biomedical/legislation & jurisprudence , Technology Assessment, Biomedical/organization & administration , Treatment Outcome
19.
Australas J Ageing ; 32(2): 91-6, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23773247

ABSTRACT

AIM: To examine views of Australian consumers, service providers and policy representatives on important characteristics and outcomes for community care. METHOD: Interviews, with 32 consumers (one person with dementia (PWD) and 31 carers), 32 service providers and four policy representatives, were analysed thematically. RESULTS: Outcomes important to consumers and service providers were that PWD can stay at home safely with personalised activities and socialisation; and that carers receive emotional support, respite and continue paid employment. Consumers and service providers said it was important that community care services were flexible and reliable and provided adequate hours of care and there was continuity of appropriate and well-trained staff. Overall responses of policy representatives were congruent with consumers and service providers but did not comprehensively cover the issues. CONCLUSIONS: Community care policies and service practices need to be re-examined to make sure that they are person-centred and reflect consumer needs, for instance by integrating client and carer services and providing appropriate activities for PWD.


Subject(s)
Administrative Personnel/psychology , Attitude of Health Personnel , Community Health Services , Consumer Behavior , Dementia/therapy , Health Knowledge, Attitudes, Practice , Health Policy , Health Services for the Aged , Outcome and Process Assessment, Health Care , Adult , Aged , Aged, 80 and over , Caregivers/psychology , Community Health Services/legislation & jurisprudence , Cost of Illness , Delivery of Health Care, Integrated , Dementia/diagnosis , Dementia/physiopathology , Dementia/psychology , Female , Health Services Needs and Demand , Health Services for the Aged/legislation & jurisprudence , Humans , Male , Middle Aged , New South Wales , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Patient Satisfaction , Patient-Centered Care , Treatment Outcome
20.
Clin Orthop Relat Res ; 471(11): 3475-81, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23625577

ABSTRACT

BACKGROUND: An emphasis on "value" over volume in health care is driving new healthcare measurement, delivery, and payment models. Orthopaedic surgery is a major contributor to healthcare spending and, as such, is the focus of many of these new models. WHERE ARE WE NOW?: An evaluation of "value" in orthopaedics requires information that has not traditionally been collected as part of routine clinical practice. If value is defined as patient outcomes in relation to healthcare costs, we need to collect information about both. In orthopaedics, patient-reported functional status is not routinely measured, and a poor understanding of the costs associated with the provision of musculoskeletal care limits our ability to quantify and report on financial measures. WHERE DO WE NEED TO GO?: To improve the value of musculoskeletal care, we need to focus on both improving outcomes and controlling costs. To improve outcomes, orthopaedists must agree on a set of outcome measures for appropriate care and advocate for their collection through the use of registries. Orthopaedic registries in several countries provide best practices for this information collection and sharing. In the United States, we should make comparable investments in registries to measure patient-reported outcomes. To address escalating costs, we need to improve the accuracy of cost data by applying modern cost accounting processes. HOW DO WE GET THERE?: Orthopaedists should take a leadership position in the promotion and implementation of value-based health care by advocating for the use of registries to measure risk-adjusted patient specific outcomes, negotiating with payors for value-based payment incentives and applying modern cost accounting processes to control costs rather than waiting for public and private payors to define components of the value equation that will affect how orthopaedic surgeons are evaluated and compensated in the future.


Subject(s)
Health Policy/legislation & jurisprudence , Orthopedic Procedures/legislation & jurisprudence , Outcome and Process Assessment, Health Care/legislation & jurisprudence , Quality Indicators, Health Care/legislation & jurisprudence , Value-Based Purchasing/legislation & jurisprudence , Cost-Benefit Analysis , Evidence-Based Medicine/legislation & jurisprudence , Health Care Costs , Health Care Reform/legislation & jurisprudence , Health Policy/economics , Health Services Research , Humans , Models, Economic , Orthopedic Procedures/adverse effects , Orthopedic Procedures/economics , Outcome and Process Assessment, Health Care/economics , Policy Making , Quality Indicators, Health Care/economics , Registries , Risk Assessment , Risk Factors , Surveys and Questionnaires , Treatment Outcome , Value-Based Purchasing/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...